AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18472364 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy (BT)
Number of subjects: 132
Study 18472364 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiation/cyberknife (SRT/CBK)
Number of subjects: 132
Study 18472364 — intervention group
Group type: COMPARATOR
Intervention: First booster dose (46-70 Gy)
Number of subjects: 132
Study 18472364 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose in the superior constrictor muscle
Number of subjects: 132
Study 16864841 — intervention group
Group type: EXPERIMENTAL
Intervention: DMS48 visual recognition memory test
Number of subjects: 0
Study 16864841 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of high-risk patients for Alzheimer's disease (AD)
Number of subjects: 0
Study 12658089 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned phacoemulsification (PEA) with IOL insertion after PKP
Number of subjects: 20
Study 12658089 — intervention group
Group type: COMPARATOR
Intervention: Triple procedure: Penetrating keratoplasty (PKP) and extracapsular cataract extraction (ECCE) with IOL insertion
Number of subjects: 20
Study 12658089 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate with 2.5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate with 5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol valerate with 2.5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol valerate with 5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate increased to 2 mg after 6 months with 2.5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 10739508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate increased to 2 mg after 6 months with 5 mg medroxyprogesterone acetate
Number of subjects: 419
Study 9256140 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐CSF (8 x 10(6) U/d)
Number of subjects: 198
Study 9256140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 8353925 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 666
Study 3658907 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy (2 l/min overnight from 22 hrs to 6 hrs)
Number of subjects: 14
Study 3658907 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 14
Study 29808033 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP during follow-up
Number of subjects: 3147
Study 29808033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic BP during follow-up
Number of subjects: 3147
Study 29808033 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean BP during follow-up
Number of subjects: 3147
Study 29808033 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 3147
Study 29808033 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP and Diastolic BP during follow-up
Number of subjects: 3147
Study 26803525 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training (EMST) with a 70% threshold value of maximal expiratory pressure, using an EMST device, 5 days a week for 4 weeks.
Number of subjects: 27
Study 26803525 — intervention group
Group type: COMPARATOR
Intervention: Placebo group trained with a sham device.
Number of subjects: 27
Study 26329473 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg/d)
Number of subjects: 72
Study 26329473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 26329473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fructose diet
Number of subjects: 72
Study 26329473 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 72
Study 22625182 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary Feeding Group (CFG) - received ICDS plus WHO recommendations on breastfeeding and complementary foods.
Number of subjects: 600
Study 22625182 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Complementary Feeding and Play Group (RCF&PG) - received the same intervention as CFG plus skills for responsive feeding and psychosocial stimulation.
Number of subjects: 600
Study 22625182 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - received routine Integrated Child Development Services (ICDS).
Number of subjects: 600
Study 21148267 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole shoe wedge and augmented pressure sensor (I-ShoWS)
Number of subjects: 35
Study 21148267 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment programme
Number of subjects: 35
Study 18186995 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 200/6 microg one puff once daily and as required (active group)
Number of subjects: 71
Study 18186995 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 200 microg one puff twice daily plus their own short‐acting beta(2)‐agonist as required (control group)
Number of subjects: 71
Study 16603852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg each night)
Number of subjects: 33
Study 16603852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 12741624 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC
Number of subjects: 18
Study 12741624 — intervention group
Group type: COMPARATOR
Intervention: ABC+3TC
Number of subjects: 18
Study 11115733 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute antipsychotic drug administration
Number of subjects: 21
Study 11115733 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (maintained on APDs)
Number of subjects: 21
Study 8833207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (60 mg, intravenously)
Number of subjects: 43
Study 8833207 — intervention group
Group type: COMPARATOR
Intervention: Clodronate (1500 mg, intravenously)
Number of subjects: 43
Study 8833207 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate (0.5-2 mg, intravenously)
Number of subjects: 43
Study 8365276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (washed RBCs autotransfused)
Number of subjects: 38
Study 8365276 — intervention group
Group type: COMPARATOR
Intervention: Control group (washed cells discarded)
Number of subjects: 38
Study 8365276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion
Number of subjects: 38
Study 8365276 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 2427904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight dextran 40 (Thomaedex 40)
Number of subjects: 0
Study 2427904 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 40/05 (Expafusin)
Number of subjects: 0
Study 29705445 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter orange (500 mg capsules)
Number of subjects: 156
Study 29705445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender (500 mg capsules)
Number of subjects: 156
Study 29705445 — intervention group
Group type: COMPARATOR
Intervention: Control (500 mg capsules containing starch)
Number of subjects: 156
Study 29705445 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter orange vs Lavender
Number of subjects: 156
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default sides
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default beverages
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default sides in quick-service restaurants
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default beverages in quick-service restaurants
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default sides in table-service restaurants
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy default beverages in table-service restaurants
Number of subjects: 145
Study 30417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy defaults
Number of subjects: 145
Study 24529610 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual switch to iloperidone
Number of subjects: 500
Study 24529610 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate switch to iloperidone
Number of subjects: 500
Study 24529610 — intervention group
Group type: COMPARATOR
Intervention: Both gradual and immediate switch groups
Number of subjects: 500
Study 22644009 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycophosphopeptical (1 g every 8 hours for 4 weeks)
Number of subjects: 38
Study 22644009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 22644009 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycophosphopeptical
Number of subjects: 38
Study 21102963 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with local anesthetic (lidocaine 0.5%)
Number of subjects: 140
Study 21102963 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with 0.5% lidocaine mixed with 1 mL of 6 mg non-particulate Celestone
Number of subjects: 140
Study 19337408 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal encapsulated cytarabine (DepoCyte)
Number of subjects: 0
Study 19337408 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 15671101 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-rich diet
Number of subjects: 59
Study 15671101 — intervention group
Group type: COMPARATOR
Intervention: CHO-rich diet
Number of subjects: 59
Study 15671101 — intervention group
Group type: COMPARATOR
Intervention: SFA-rich diet
Number of subjects: 59
Study 15671101 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 59
Study 14765609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated bonding agent with fluoridated composite resin (Group III)
Number of subjects: 60
Study 14765609 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐fluoridated bonding agent with fluoridated composite (Group II)
Number of subjects: 60
Study 14765609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated bonding agent with non‐fluoridated composite (Group I)
Number of subjects: 60
Study 10391396 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (100 mg) alone
Number of subjects: 11
Study 10391396 — intervention group
Group type: COMPARATOR
Intervention: Captopril (100 mg) in combination with bendrofluazide (2.5 mg)
Number of subjects: 11
Study 8897080 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A
Number of subjects: 24
Study 8897080 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment B
Number of subjects: 24
Study 1706501 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine 250 mg/day (group A)
Number of subjects: 111
Study 1706501 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 111
Study 6472606 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 6472606 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological testing
Number of subjects: 0
Study 31387894 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear load pressure
Number of subjects: 40
Study 31387894 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear load pressure
Number of subjects: 40
Study 31387894 — intervention group
Group type: COMPARATOR
Intervention: Control (Conventional respiratory physiotherapy)
Number of subjects: 40
Study 29361335 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg moxidectin
Number of subjects: 1499
Study 29361335 — intervention group
Group type: COMPARATOR
Intervention: 150 μg/kg ivermectin
Number of subjects: 1499
Study 26071564 — intervention group
Group type: EXPERIMENTAL
Intervention: SCL-90-R (Symptom Checklist) assessment for psychological distress
Number of subjects: 0
Study 26071564 — intervention group
Group type: EXPERIMENTAL
Intervention: SCL-90-R assessment
Number of subjects: 0
Study 26071564 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 0
Study 23680969 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable partial dental prostheses (RPDP)
Number of subjects: 215
Study 23680969 — intervention group
Group type: COMPARATOR
Intervention: Shortened dental arch (SDA)
Number of subjects: 215
Study 22455549 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed diode laser with a large spot size and vacuum-assisted suction
Number of subjects: 35
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of mechanical ventilation
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwhite race
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of organ failures
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressors
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: IV fluids
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical vs medical service
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1505
Study 20363840 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 1505
Study 18318924 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine system
Number of subjects: 1500
Study 18318924 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 1500
Study 15759454 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg/day
Number of subjects: 83
Study 15759454 — intervention group
Group type: COMPARATOR
Intervention: Metformin 1000 mg/day
Number of subjects: 83
Study 11954669 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention based on the Progressively Lowered Stress Threshold (PLST) model
Number of subjects: 241
Study 11954669 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 241
Study 10027371 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevertebral gastric tube reconstruction
Number of subjects: 60
Study 10027371 — intervention group
Group type: COMPARATOR
Intervention: Retrosternal gastric tube reconstruction
Number of subjects: 60
Study 7732693 — intervention group
Group type: COMPARATOR
Intervention: 30% of individual maximal physical working capacity (PWC)
Number of subjects: 30
Study 7732693 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% of individual maximal physical working capacity (PWC)
Number of subjects: 30
Study 7732693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (30% and 50% intensity)
Number of subjects: 30
Study 2201940 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete and timely course of antenatal glucocorticoids
Number of subjects: 223
Study 2201940 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial course of antenatal glucocorticoids
Number of subjects: 223
Study 2201940 — intervention group
Group type: COMPARATOR
Intervention: No glucocorticoids
Number of subjects: 223
Study 7046699 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 15mg daily for 14 days
Number of subjects: 40
Study 7046699 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 40
Study 7046699 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 40
Study 7046699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31141445 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicine ball plyometric training (8 weeks, thrice per week)
Number of subjects: 59
Study 31141445 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study 31842937 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention package including training in occupational health, formation of workplace committees, health and safety plan promotion, and provision of face-masks.
Number of subjects: 28
Study 31842937 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 28587520 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet adaptation of an evidence-based infant parenting intervention
Number of subjects: 0
Study 28587520 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25830446 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (RAISE‐ETP)
Number of subjects: 404
Study 25830446 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 404
Study 23836967 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii Fit training (3 times a week for 3 weeks)
Number of subjects: 12
Study 23836967 — intervention group
Group type: COMPARATOR
Intervention: Normal activities (Control)
Number of subjects: 12
Study 21590273 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mL of 4% articaine with 1:100,000 epinephrine
Number of subjects: 10
Study 21590273 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mL of 4% articaine with 1:100,000 epinephrine
Number of subjects: 10
Study 21590273 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 mL of 4% articaine with 1:100,000 epinephrine
Number of subjects: 10
Study 19594937 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF-DPI) 200 microg once daily (QD)
Number of subjects: 233
Study 19594937 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF-DPI) 100 microg twice daily (BID)
Number of subjects: 233
Study 19594937 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate metered dose inhaler (BDP-MDI) 168 microg BID
Number of subjects: 233
Study 17577003 — intervention group
Group type: EXPERIMENTAL
Intervention: 54 mg of genistein daily for 24 months
Number of subjects: 389
Study 17577003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 15028450 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide monotherapy
Number of subjects: 48
Study 15028450 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic castration
Number of subjects: 48
Study 11380968 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound
Number of subjects: 65
Study 11380968 — intervention group
Group type: COMPARATOR
Intervention: Transrectal ultrasound
Number of subjects: 65
Study 9726277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release naltrexone (NTX) 206 mg subcutaneous injection
Number of subjects: 20
Study 9726277 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 20
Study 8277105 — intervention group
Group type: EXPERIMENTAL
Intervention: GAU intervention for rehabilitation classification
Number of subjects: 155
Study 8277105 — intervention group
Group type: EXPERIMENTAL
Intervention: GAU intervention for medical-surgical classification
Number of subjects: 155
Study 8277105 — intervention group
Group type: EXPERIMENTAL
Intervention: GAU intervention for both classifications
Number of subjects: 155
Study 2690599 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental NHS nursing homes
Number of subjects: 0
Study 2690599 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10439 — intervention group
Group type: EXPERIMENTAL
Intervention: Antirheumatic drugs
Number of subjects: 684
Study 10439 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain response measured using a daily pain chart
Number of subjects: 684
Study 10439 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' satisfaction rating
Number of subjects: 684
Study 10439 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean number of days withdrawn
Number of subjects: 684
Study 31282059 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (LVX)
Number of subjects: 13
Study 31282059 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin (GXN)
Number of subjects: 13
Study 31282059 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MXN)
Number of subjects: 13
Study 27053574 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured patient education ambulatory program combined with weekly sessions of dance therapy
Number of subjects: 67
Study 27053574 — intervention group
Group type: COMPARATOR
Intervention: Structured patient education ambulatory program
Number of subjects: 67
Study 25095738 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy with clopidogrel (75 mg) plus aspirin (300 mg)
Number of subjects: 325
Study 25095738 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy (300 mg)
Number of subjects: 325
Study 23358123 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (ExQW) 2 mg
Number of subjects: 295
Study 21970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease participants
Number of subjects: 387
Study 21970467 — intervention group
Group type: COMPARATOR
Intervention: Cognitively healthy controls
Number of subjects: 387
Study 21970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing home residents with Alzheimer's disease
Number of subjects: 387
Study 21970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease participants living at home
Number of subjects: 387
Study 19349892 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncultured keratinocyte/melanocyte cosuspension
Number of subjects: 0
Study 19349892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17400593 — intervention group
Group type: EXPERIMENTAL
Intervention: HAMLET (surgical decompression)
Number of subjects: 60
Study 17400593 — intervention group
Group type: COMPARATOR
Intervention: PAIS (Paracetamol in Stroke)
Number of subjects: 60
Study 17400593 — intervention group
Group type: EXPERIMENTAL
Intervention: HAMLET and PAIS (informed consent appreciation)
Number of subjects: 60
Study 15200749 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg zoledronic acid intravenously yearly
Number of subjects: 1714